Virtual Medicine

InfoBionic Rebrands Company Name to ‘InfoBionic.Ai’, Reinforcing Focus on AI-Enabled ECG

Retrieved on: 
Tuesday, April 9, 2024

InfoBionic has always been dedicated to remaining at the cutting edge of patient care.

Key Points: 
  • InfoBionic has always been dedicated to remaining at the cutting edge of patient care.
  • Since the organization’s inception in 2015, AI and machine learning have been an integral part of InfoBionic’s remote cardiac telemetry offering.
  • In reality, this name change is just formalizing what we have already become,” says Stuart Long, CEO of InfoBionic.Ai.
  • “Our commitment to evolving remote cardiac telemetry monitoring through existing and novel AI-enabled ECG remains steadfast and unwavering.

New Study Finds AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration and Significantly Reduce False Alarms for Clinicians

Retrieved on: 
Tuesday, April 9, 2024

The prediction models used in the study are a part of CLEW’s intelligent clinical surveillance platform.

Key Points: 
  • The prediction models used in the study are a part of CLEW’s intelligent clinical surveillance platform.
  • It also supports the health system with capacity management, by providing early identification of potential bottlenecks caused by unexpected deterioration.
  • In addition to demonstrating its superior accuracy, the study concluded that the CLEW system generated 50-times fewer alarms than other leading systems.
  • In busy and overburdened critical care environments, this can greatly reduce alarm fatigue and the associated cognitive burden on caregivers.

Collette Health Debuts Three Major Platform Enhancements at AONL 2024 Conference to Increase Patient Safety

Retrieved on: 
Tuesday, April 9, 2024

Collette Health , a leading provider of continuous virtual patient observation solutions, announced today at the 2024 American Organization for Nursing Leadership (AONL) Conference three new major platform enhancements to increase patient safety and allow care from anywhere.

Key Points: 
  • Collette Health , a leading provider of continuous virtual patient observation solutions, announced today at the 2024 American Organization for Nursing Leadership (AONL) Conference three new major platform enhancements to increase patient safety and allow care from anywhere.
  • “This is a major milestone for Collette Health, and we’re proud to unveil and introduce these new features at AONL in front of thousands of nursing leaders,” said Christine Gall, Chief Nursing Officer at Collette Health.
  • Collette Health uses a strategic and human-enabled application of AI and machine learning (ML) with its new “follow patient” feature.
  • Collette Health will be exhibiting and demonstrating its platform at the AONL Conference in New Orleans, April 9-10.

Telecare Market in Europe and North America: The User Base in the Two Regions is Estimated to Grow at a CAGR of 7.7% to Reach More Than 20.6 Million Users at the End of 2028 - ResearchAndMarkets.com

Retrieved on: 
Monday, April 8, 2024

The report estimates that the user base of telecare (medical alert) systems in Europe and North America was 14.2 million at the end of 2023.

Key Points: 
  • The report estimates that the user base of telecare (medical alert) systems in Europe and North America was 14.2 million at the end of 2023.
  • The user base in the two regions is estimated to grow at a CAGR of 7.7 percent to reach more than 20.6 million users at the end of 2028.
  • The report estimates that the user base of telecare solutions in Europe region was 9 million at the end of 2023.
  • In Europe, the user base is estimated to grow at a CAGR of 7.7 percent to reach more than 13.1 million users at the end of 2028.

iHealthScreen Inc. is Awarded a US Patent on Glaucoma Detection, Which Is Based on AI and Color Fundus Imaging

Retrieved on: 
Tuesday, April 9, 2024

The early screening and detection of glaucoma can potentially help prevent the progression to severe glaucoma and save millions of people from blindness.

Key Points: 
  • The early screening and detection of glaucoma can potentially help prevent the progression to severe glaucoma and save millions of people from blindness.
  • The entire test which includes color retinal imaging and the automated AI-based glaucoma report generation can easily and reliably be completed within 5 minutes.
  • Glaucoma detection offers an overall accuracy of 94.3% for identifying an individual with glaucoma.
  • iPredict’s glaucoma detection model can be used as follows:
    iPredict-glaucoma report will produce which will indicate referable (i.e., early to severe glaucoma) or non-referable glaucoma (not glaucoma).

SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment

Retrieved on: 
Monday, April 8, 2024

One key event during the experiment was a comprehensive multi-day army medical experiment held at Fort Irwin’s National Training Center in the Mojave Desert amidst the challenging terrains of California’s Tiefort Mountains.

Key Points: 
  • One key event during the experiment was a comprehensive multi-day army medical experiment held at Fort Irwin’s National Training Center in the Mojave Desert amidst the challenging terrains of California’s Tiefort Mountains.
  • PC-C4, a joint, multinational experiment hosted by the U.S. Army across multiple locations in February and March allowed military medicine to explore and integrate the latest technological innovations in a field environment.
  • SmartHeart’s inclusion in this prestigious experiment underscores the growing recognition of SHL’s portable ECG technology as a game-changer in the fast-paced and demanding field of military healthcare.
  • It addresses a crucial need in the continuum of military medical care from initial non-battle evaluation to trauma response, to advanced interventions for intensive and continual care.

ZCG-Backed Unimed Launches Telemedicine Solution to Further Enhance Technology Solutions For Maritime Medical Platform

Retrieved on: 
Monday, April 8, 2024

Universal Marine Medical Supply International (“Unimed” or the “Company”), the leading global provider of pharmaceutical and medical solutions to the maritime industry, today announced the launch of comprehensive telemedicine capabilities, further strengthening the Company’s technology-enabled maritime medical platform.

Key Points: 
  • Universal Marine Medical Supply International (“Unimed” or the “Company”), the leading global provider of pharmaceutical and medical solutions to the maritime industry, today announced the launch of comprehensive telemedicine capabilities, further strengthening the Company’s technology-enabled maritime medical platform.
  • Unimed’s telemedicine solution bridges this gap, providing 24/7 global access to experienced maritime doctors and nurses stationed at the Company’s medical health center in Athens, Greece.
  • The telemedicine solution is integrated into Unimed’s proprietary medScale+© digital platform, currently utilized by over 5,500 vessels through a mobile app or web browser.
  • Our telemedicine solution offers both customers and their crew members assurance of convenient access to medical care from anywhere in the world,” said Søren Andersen, CEO of Unimed.

Tempus Introduces Workspaces into its Lens Data Analytics Platform

Retrieved on: 
Saturday, April 6, 2024

Tempus, a leader in artificial intelligence and precision medicine, is broadly introducing its new Workspaces feature in the Lens platform.

Key Points: 
  • Tempus, a leader in artificial intelligence and precision medicine, is broadly introducing its new Workspaces feature in the Lens platform.
  • Workspaces is a private, coding-based cloud environment designed to unblock research and accelerate innovation.
  • This new interface provides researchers a frictionless workflow for surfacing critical insights to power scientific discovery and development.
  • Lens is already trusted by nearly 100 institutions, including healthcare systems and biopharma companies, to power research that improves patient outcomes.

Maximus Declares Quarterly Cash Dividend of $0.30 per Share

Retrieved on: 
Friday, April 5, 2024

Maximus (NYSE: MMS), a leading provider of government services worldwide, announced today that its Board of Directors has approved a quarterly cash dividend of $0.30 per share, payable on May 31, 2024, to shareholders of record on May 15, 2024.

Key Points: 

Maximus (NYSE: MMS), a leading provider of government services worldwide, announced today that its Board of Directors has approved a quarterly cash dividend of $0.30 per share, payable on May 31, 2024, to shareholders of record on May 15, 2024.

Quad Announces New Predictive Model of Consumer Attitudes in Health Insurance

Retrieved on: 
Thursday, April 4, 2024

The model is based on nationally representative, primary research about what consumers value most from their health insurance.

Key Points: 
  • The model is based on nationally representative, primary research about what consumers value most from their health insurance.
  • The research, which is detailed in Quad’s new report, “Tapping the Power of Consumer Attitudes,” uncovered three distinct segments for consumer attitudes.
  • ”Quad’s predictive model adds a new dimension to personalized, health insurance marketing,” Hickman continued “We can now create much more direct consumer connections by precisely aligning health insurance marketing messages – and even customer service scripts and product development – with what consumers have told us matters most to them.
  • For a summary of the report, “Tapping the Power of Consumer Attitudes,” or to request a full copy, visit this link or send an email to [email protected] .